Listen

Add to my selection

BRINEURA (cerliponase alfa)

Medicine - Posted on Dec 12 2024

Active substance (DCI)

cerliponase alfa

history (2)

11/27/24

BRINEURA 150 mg (cerliponase alfa) - ) Rare disease

Summary of opinion Favourable opinion for maintenance of reimbursement in “the treatment of neuronal ceroid lipofuscinosis t...

CAV :
54321

icône flèche
6/20/18

BRINEURA (cerliponase alfa), simple class

High clinical benefit for neuronal ceroid lipofuscinosis type 2 and moderate clinical added value in the management of this ...

CAV :
54321

icône flèche

Technical information

ATC code

A16AB17

Manufacturer

BIOMARIN INTERNATIONAL LIMITED

Presentation

BRINEURA 150 mg, solution pour perfusion (code CIS : 65808346)
2 flacon(s) en verre de 5 ml - 1 flacon(s) en verre de 5 ml (CIP : 34009 550 337 1 4)

All our publications

Congenital, genetic and rare diseases

Metabolic diseases

Neurodegenerative diseases